Niskayuna, NY, United States of America

Robert Campbell

USPTO Granted Patents = 15 

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 41(Granted Patents)


Location History:

  • Corrales, NM (US) (2014 - 2022)
  • Niskayuna, NY (US) (2015 - 2023)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
15 patents (USPTO):

Title: **Robert Campbell: A Pioneer in Phosphodiesterase Inhibition**

Introduction

Robert Campbell, an accomplished inventor based in Niskayuna, NY, has made significant contributions to the field of medicinal chemistry. With a total of 15 patents to his name, his work primarily focuses on developing innovative compounds to combat inflammatory diseases.

Latest Patents

Among his most notable inventions are the recent patents related to heteroaryl inhibitors of phosphodiesterase 4 (PDE4). These inventions comprise compounds and methods aimed at treating or preventing inflammatory diseases and other ailments associated with elevated levels of cytokines and proinflammatory mediators. His dedication to advancing this field showcases the potential impact of his research on public health.

Career Highlights

Robert has a distinguished career, having worked with Tetra Discovery Partners, LLC, where he applied his expertise in medicinal chemistry. His innovations have garnered attention within the pharmaceutical industry, affirming his role as a vital contributor to drug development.

Collaborations

Throughout his career, Robert Campbell has collaborated with several accomplished professionals, including Mark E. Gurney and Timothy J. Hagen. These partnerships have been instrumental in bringing his groundbreaking ideas to fruition, fostering an environment of creativity and innovation.

Conclusion

Robert Campbell’s contributions to the field of medicinal chemistry exemplify the spirit of innovation. His work with PDE4 inhibitors not only reflects his dedication to science but also holds the promise of improving treatments for inflammatory diseases, thereby benefiting patients worldwide. As he continues to innovate, the medical community eagerly anticipates his future discoveries and advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…